A model of skin inflammation in humans leads to a rapid and reproducible increase in the interferon response signature: a potential translational model for drug development
暂无分享,去创建一个
[1] P. C. van de Kerkhof,et al. Are Newly Discovered Drivers of Immune-Mediated Skin Disorders Expressed in Normal Skin Regenerating from Standardized Surface Injury? , 2014, Dermatology.
[2] Amitava Das,et al. Engulfment of Apoptotic Cells by Macrophages: A Role of MicroRNA-21 in the Resolution of Wound Inflammation , 2014, The Journal of Immunology.
[3] T. Elton,et al. Regulation of the MIR155 host gene in physiological and pathological processes. , 2013, Gene.
[4] S. Pfeffer,et al. The miR-17 ∼ 92 Cluster: A Key Player in the Control of Inflammation during Rheumatoid Arthritis , 2013, Front. Immunol..
[5] Zhongmin Liu,et al. MicroRNA-7–regulated TLR9 signaling–enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway , 2013, Molecular biology of the cell.
[6] Zhongmin Liu,et al. MicroRNA-574-5p Was Pivotal for TLR9 Signaling Enhanced Tumor Progression via Down-Regulating Checkpoint Suppressor 1 in Human Lung Cancer , 2012, PloS one.
[7] Jianni Qi,et al. microRNA‐210 negatively regulates LPS‐induced production of proinflammatory cytokines by targeting NF‐κB1 in murine macrophages , 2012, FEBS letters.
[8] M. Chan,et al. Lupus erythematosus-like reaction in imiquimod-treated skin: a report of 2 cases. , 2011, The American Journal of dermatopathology.
[9] Andrew Johnston,et al. Genome-Wide Expression Profiling of Five Mouse Models Identifies Similarities and Differences with Human Psoriasis , 2011, PloS one.
[10] R. Coffman,et al. Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9 , 2010, The Journal of experimental medicine.
[11] Gang Wang,et al. Serum and Urinary Cell–free MiR-146a and MiR-155 in Patients with Systemic Lupus Erythematosus , 2010, The Journal of Rheumatology.
[12] H. Dickel,et al. Standardized tape stripping prior to patch testing induces upregulation of Hsp90, Hsp70, IL‐33, TNF‐α and IL‐8/CXCL8 mRNA: new insights into the involvement of ‘alarmins’ , 2010, Contact dermatitis.
[13] Yuanjia Tang,et al. MicroRNA-21 and MicroRNA-148a Contribute to DNA Hypomethylation in Lupus CD4+ T Cells by Directly and Indirectly Targeting DNA Methyltransferase 1 , 2010, The Journal of Immunology.
[14] Frances Gotch,et al. miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator , 2010, Nature Cell Biology.
[15] E. Pålsson-McDermott,et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21 , 2010, Nature Immunology.
[16] Michael T. McManus,et al. LPS induces KH‐type splicing regulatory protein‐dependent processing of microRNA‐155 precursors in macrophages , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] D. Iliopoulos,et al. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. , 2009, Immunity.
[18] L. Boon,et al. Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1 , 2009, The Journal of Immunology.
[19] Ryan M. O’Connell,et al. Inositol phosphatase SHIP1 is a primary target of miR-155 , 2009, Proceedings of the National Academy of Sciences.
[20] Michael Detmar,et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. , 2008, Arthritis and rheumatism.
[21] M. Schön,et al. Imiquimod: mode of action , 2007, The British journal of dermatology.
[22] Lars Karlsson,et al. TLR7/9 antagonists as therapeutics for immune-mediated inflammatory disorders. , 2007, Inflammation & allergy drug targets.
[23] J. Wenzel,et al. Identification of type I interferon‐associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches , 2007, Experimental dermatology.
[24] D. Marks,et al. Modified skin window technique for the extended characterisation of acute inflammation in humans , 2007, Inflammation Research.
[25] T. Bieber,et al. Enhanced type I interferon signalling promotes Th1‐biased inflammation in cutaneous lupus erythematosus , 2005, The Journal of pathology.
[26] G. Stingl,et al. Identification and Characterization of pDC-Like Cells in Normal Mouse Skin and Melanomas Treated with Imiquimod1 , 2004, The Journal of Immunology.
[27] Byun,et al. Patients with Systemic Lupus Erythematosus , 1999 .
[28] B. Nickoloff,et al. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. , 1994, Journal of the American Academy of Dermatology.
[29] P. Elias,et al. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. , 1992, The Journal of clinical investigation.
[30] J. Streilein,et al. Depletion of epidermal langerhans cells and Ia immunogenicity from tape- stripped mouse skin , 1982, The Journal of experimental medicine.